-
The choice of viral load endpoint in early phase trials of COVID-19 treatments aiming to reduce 28-day hospitalization and/or death J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-04
Allyson Mateja, Eric Chu, Thomas A Murray, Carolyn T Bramante, Carlee Moser, Naomi Givens, Mazin Abdelghany, Chris Blair, Shuguang Chen, Prince Kumar Lat, Ofir Harari, Nicole L Kallewaard, Lisa Farmer Macpherson, David R Boulware, Clara Suñer, Oriol Mitjà, Stacey J Adam, Victor De Gruttola, Michael D Hughes, Daniel Rubin, Davey M Smith, Gail E PotterBackground Virologic endpoints are used in Phase 2 trials for COVID-19 therapeutics, but they have not been established as surrogates for clinical endpoints. No meta-analysis using individual participant data (IPD) has been undertaken to identify viral load outcomes for which treatment effects are best associated with effects on hospitalization/death. Methods This meta-analysis combined IPD from 23
-
B-Cell Subset Representation Predicts SARS-CoV-2 Vaccine Response in Solid Organ Transplant Recipients J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-03
James J Knox, Ingi Lee, Emily A Blumberg, Aaron M Rosenfeld, Wenzhao Meng, Fang Liu, Charlotte Kearns, Una O’Doherty, Abraham Shaked, Kim M Olthoff, Eline T Luning PrakBackground Solid organ transplant recipients (SOTRs) suffer increased morbidity and mortality due, in part, to chronic immunosuppression. The determination of an individual's immune competence is currently difficult but would improve risk assessment and inform medical decisions. We reasoned that correlating qualitative and quantitative measures of the B-cell compartment with serologic responses to
-
Using Machine Learning Algorithms to Identify Key Predictors of Invasive Mold Infection Surveillance J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-03
Samantha L Williams, Zainab Salah, Brendan R Jackson, Sebastian Wurster, Jose A Serpa, Carolyn Z Grimes, Robert L Atmar, Tom M Chiller, Dimitrios P Kontoyiannis, Luis Ostrosky-Zeichner, Mitsuru TodaBackground Invasive mold infections (IMI) can lead to severe morbidity and mortality, but routine public health surveillance is lacking. Although extensive evaluation is needed for clinical diagnosis, case classification prediction models may inform surveillance efforts, which are essential to better characterize epidemiologic trends and assess the value of a more inclusive IMI case definition. Methods
-
Differentiating SARS-CoV-2 antibody responses between infection and vaccination: challenges for epidemiological research J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-03
Sunav N Nayagam, William Coote, Matthew T C Carroll, Zheng Quan Toh, Paul V Licciardi, Michael J Abramson, Karen Walker-Bone, Tyler J LaneSome common COVID-19 vaccines elicit antibody responses that most serological tests are unable to differentiate from an infection response. This presents a challenge for COVID-19 surveillance and epidemiology. In this perspective, we examine the potential scale of this problem.
-
Functional and structural characterization of treatment-emergent nirmatrelvir resistance mutations at low frequencies in the main protease (Mpro) reveals a unique evolutionary route for SARS-CoV-2 to gain resistance J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-03
Natalie M Deschenes, Jimena Pérez-Vargas, Zoe Zhong, Merrilee Thomas, Calem Kenward, Wesley A Mosimann, Liam J Worrall, Nicholas Waglechner, Angel XinLiu Li, Finlay Maguire, Patryk Aftanas, Jason R Smith, Jared Lim, Robert N Young, Artem Cherkasov, Lubna Farooqi, Adnan Moinuddin, Lina Siddiqi, Imaan Malik, Maxime Lefebvre, Mark Paetzel, Natalie C J Strynadka, François Jean, Allison McGeer, Robert ABackground The main protease (Mpro) is one of the most attractive targets for antiviral drug discovery against SARS-CoV-2. Mutations in Mpro have been linked to resistance against nirmatrelvir-ritonavir (NIR-RIT), an important therapy for SARS-CoV-2 infection. This study aimed to identify low-frequency antiviral resistance mutations in Mpro from NIR-RIT-treated patients and to analyze the enzymatic
-
Impact of puberty on immune responses to Mycobacterium tuberculosis in South African adolescents J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-02
Léanie Kleynhans, Elizna Maasdorp, Candice I Snyders, James A SeddonBackground As individuals progress through adolescence, their risk of tuberculosis (TB) increases and the type of disease that develops changes, with increasing cavitary formation and parenchymal tissue destruction. While it is widely assumed that the changes in risk and disease phenotype are due to puberty exerting an impact on host immune responses to Mycobacterium tuberculosis, this relationship
-
Host determinants for the spread of PVL-positive Staphylococcus aureus in Sub-Saharan Africa J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-31
Tobias Grebe, Viktoria Rudolf, Christiane Sidonie Gouleu, Tomiwa Olumide Adesoji, Claujens Chastel Mfoutou Mapanguy, Mary Oladokun, Anke Siegmund, Le Thi Kieu Linh, Silke Niemann, Bettina Löffler, Ayola Akim Adegnika, Francine Ntoumi, Thirumalaisamy P Velavan, Adebayo Osagie Shittu, Frieder SchaumburgThe Panton-Valentine leukocidin (PVL) of Staphylococcus aureus can be associated with severe and recurrent skin and soft tissue infections (SSTI). The prevalence of PVL is particularly high in Sub-Saharan Africa. We assessed in a multi-center cross-sectional study whether host-related factors could explain this high PVL prevalence. We find higher serum anti-PVL-IgG levels in participants from Africa
-
Genome-scale meta-analysis of host responses to Staphylococcus aureus identifies pathways for host-directed therapeutic targeting J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-31
Clark D Russell, Seraphima Goeldner-Thompson, Emilie Smith, Jonathan E Millar, Bo Wang, Nicholas Parkinson, Sara Clohisey Hendry, Maaike Swets, J Ross Fitzgerald, J Kenneth Baillie, David H DockrellBackground Staphylococcus aureus infections are frequently complicated by metastatic foci, recurrence, and death. Antimicrobial resistance and intracellular bacterial persistence limit the effectiveness of conventional antimicrobials. Host-directed therapies could improve outcomes, but the interpretive complexity of pathogen-host interactions impedes identification of critical responses suitable for
-
Longitudinal Analysis of Nasopharyngeal Microbial Risk Markers for Fatal Acute Febrile Illness in a Zambian Birth Cohort J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-31
Aubrey R Odom, Jessica Anderson, Christopher J Gill, Rachel Pieciak, Arshad Ismail, William B MacLeod, W Evan Johnson, Rotem LapidotIntroduction Fatal acute febrile illness (fAFI) is a known predecessor of many infant mortality events in low-resource settings, yet early risk markers for this condition remain poorly understood. Nasopharyngeal (NP) microbiome patterns may influence the severity of these infections. Methods We analyzed longitudinal changes in the NP microbiota of Zambian infants with fAFI onset compared to healthy
-
Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV Surrogate and Douche (DREAM-02) J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-31
Ruohui Zheng, Edward J Fuchs, Sridhar Nimmagadda, Lisa C Rohan, Lin Wang, Lynn N Bertagnolli, Sandra Massih, Brian S Caffo, Craig W HendrixBackground Men who have sex with men are at high risk of HIV acquisition through unprotected receptive anal intercourse (RAI). Behaviorally-congruent HIV PrEP has long been advocated by individuals who find adherence challenging or prefer minimizing systemic drug concentrations. We developed an event-driven, behaviorally-congruent rectal tenofovir (TFV) douche as a PrEP option for RAI and demonstrated
-
Functional genomics of antibiotic susceptibility in Enterococcus faecalis from infective endocarditis J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-30
Yanhong Li, Madison E Stellfox, Kirsten M Evans, Emma G Mills, Kevin M Squires, Ava J Dorazio, Ryan K Shields, Daria Van TyneEnterococcus faecalis is an opportunistic pathogen that causes infective endocarditis. Despite in vitro synergy of the recommended combination ampicillin and ceftriaxone (AC), E. faecalis infective endocarditis (EFIE) mortality remains high. We characterized 119 isolates from EFIE patients in our health system from 2018 to 2023 genomically and phenotypically. Three genetic lineages (ST6, ST40, and
-
Differences in Neutrophil Counts Between African and non-African Countries in two International Clinical Trials J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Ruth N Moro, John L Johnson, Neil Martinson, Grace Muzanyi, Chi-Chiu Leung, Kwok-Chiu Chang, Ziyaad Waja, Stefan V GoldbergBackground Differences in absolute neutrophil count (ANC) between African and non-African populations have been reported. Neutropenia has also been reported during rifamycin use. ANC values in current tables that assign severity grades to clinical or laboratory events (The National Cancer Institute Common Terminology Criteria for Adverse Events [CTCAE] and the National Institute of Allergy and Infectious
-
Efficacy of RTS,S/AS01E only seen in baseline parasitemic and not baseline aparasitemic Plasmodium falciparum-exposed, drug-treated Kenyan adults J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Nathanial K Copeland, Lucas Otieno, June Doryne Otieno, Solomon Otieno, Salome Chira, Karen Ivinson, Irene Onyango, Ruth Wasuna, Hoseah Akala, Amos Onditi, Peter Sifuna, Ben Andagalu, Roselyne Oyugi, Mary Omondi, Stellah Amoit, Emily Locke, Scott Gregory, Elke S Bergmann-Leitner, Hema Pindolia, Mike Raine, Chris Gast, Laina D Mercer, John J Aponte, Marc Lievens, Christian F Ockenhouse, Cynthia K LeeBackground RTS,S/AS01 vaccine efficacy (VE) was previously shown as lower in African adults than in malaria-naïve US adults, potentially due to concurrent Plasmodium falciparum (Pf) infections. We investigated whether treatment of infection prior to vaccination would lead to improved VE and immunogenicity. Methods A Phase 2b study in Kenyan adults evaluated the efficacy of RTS,S/AS01E in conjunction
-
Impact of Population Immunity and Public Health Measures on the Transmission of Omicron Subvariants BA.2 and BA.5 in Hong Kong J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Can Wang, Hsiang-Yu Yuan, Eric H Y Lau, Benjamin J Cowling, Dennis K M Ip, Tim K TsangBackground The rapid evolution of SARS-CoV-2 and population-level vaccine administration significantly shift the population immunity. In Hong Kong, these shifts, coupled with the emergence of Omicron BA.5 with a strong ability of immune evasion, necessitate a deeper understanding of how population immunity and public health and social measures have shaped the epidemic dynamics across age groups within
-
HIV-Superinfection in Kidney Transplant Recipients with HIV who Received Organs from Donors with HIV J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Gracie M Rozek, Ping Yang, Yolanda Eby, Sarah E Benner, Craig Martens, Feben Habtehyimer, Maggie Chahoud, Diane Brown, Niraj M Desai, Sander Florman, Meenakshi M Rana, Marcus R Pereira, Jonathan Hand, Sapna A Mehta, Joanna Schaenman, Carlos A Q Santos, Saima Aslam, Nahel Elias, Jonah Odim, Megan Morsheimer, Dorry L Segev, Christine M Durand, Aaron A R Tobian, Andrew D ReddTransplantation of kidneys from donors with HIV to recipients with HIV (HIV D+/R+) has been shown to be safe and effective, but there is a unique risk of donor-derived HIV-superinfection (HIV-SI) in these recipients. Recipients from a multicenter observational HIV D+/R+ study were examined for HIV-SI using site-directed next-generation sequencing (Illumina). Eighteen HIV D+/R+ kidney transplant recipients
-
Tracing the Origin of the 2022 Dengue Virus Epidemic in Karachi, Pakistan, through Genome Analyses J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Jeeyou Kim, Minkyu Park, Donghoon Shin, Zohaib Ul Hassan, Ibrar Ahmed, Nazish Badar, Mohammed Saeed Quraishy, Salman Ahmed Khan, Misbah Anwar, Nur A Hasan, Min-gyung Baek, Seil Kim, Hana YiBackground The 2022 dengue outbreak in Karachi, Pakistan, posed a severe threat to the region, yet no study has investigated the origins of the causal strain. Methods This study aimed to trace the origins and transmission route of the dengue virus serotype 1 (DENV-1) strain responsible for the 2022 epidemic through genome sequencing and phylogenetic analyses. We successfully sequenced 135 complete
-
Single-cell targeted transcriptomics reveals subset-specific immune signatures differentiating asymptomatic and cardiac patients with chronic Chagas disease J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-28
Thaiany G Souza-Silva, Amanda Figueiredo, Katia L P Morais, Juliana Apostólico, Alexandre Pantaleao, Antônio Mutarelli, Silvana Silva Araújo, Maria do Carmo Pereira Nunes, Kenneth J Gollob, Walderez O DutraBackground Human infection with Trypanosoma cruzi leads to Chagas disease that induces profound changes in the immune response across different cell subsets, influencing parasite control and disease pathology. Dissecting the functional characteristics of distinct immune cells in patients with the asymptomatic (indeterminate – IND) or with the cardiac (CCC) clinical forms is crucial for unveiling mechanisms
-
Mendelian randomisation and infection: pitfalls and promises J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-28
Fergus Hamilton, Guillaume Butler-Laporte, George Davey SmithMendelian randomisation (MR) is an increasingly common study design in infectious diseases (ID). It holds promise for identifying causes and consequences of infections where conventional epidemiology has struggled, and can highlight plausible drug targets, as predating successful COVID-19 trials (baricitinib, tocilizumab). However, many current applications provide limited insight due to violations
-
Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-28
Wan-Yu Chu, Ahmed H Fahal, Eiman Siddig Ahmed, Sahar Mubarak Bakhiet, Osama Elhadi Bakhiet, Lamis Ahmed Fahal, Abubakar Ahmed Mohamed, El Sammani Wadaa Mohamedelamin, Mustafa El Nour Bahar, Hadil Yassir Attalla, Emmanuel Edwar Siddig, Najwa A Mhmoud, Ahmed Mudawi Musa, Peelen Oyieko, Thaddaeus Egondi, Roger J Brüggemann, Katsura Hata, Nathalie Strub-Wourgaft, Fabiana Alves, Borna A Nyaoke, Eduard EBackground The first clinical trial on eumycetoma was recently conducted in Sudan, comparing oral fosravuconazole, prodrug of active ravuconazole, with the standard-of-care oral itraconazole. Building on this trial, the present study aimed to characterize the pharmacokinetics-pharmacodynamics (PK-PD) of ravuconazole, itraconazole and hydroxyitraconazole in patients with eumycetoma and guide selection
-
Prevotella intermedia Synergistically Exacerbates Pneumonia Induced by Oral Streptococci J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-27
Hiroki Ashizawa, Naoki Iwanaga, Kazuki Nemoto, Tatsuro Hirayama, Masataka Yoshida, Kazuaki Takeda, Shotaro Ide, Masato Tashiro, Naoki Hosogaya, Takahiro Takazono, Kosuke Kosai, Noriho Sakamoto, Koichi Izumikawa, Mariko Naito, Yoshimasa Tanaka, Katsunori Yanagihara, Kazuhiro Yatera, Hiroshi MukaeBackground The precise mechanisms of respiratory infection caused by oral anaerobic bacteria remain elusive. Unexpectedly, bacterial microbiota analysis using 16S rRNA revealed “hidden” mixed infections of anaerobic bacteria and commensal oral Streptococcus species in patients with community-acquired pneumonia (CAP). The study aimed to elucidate the mechanisms by which Prevotella intermedia exacerbates
-
Improving Molecular Epidemiological Surveillance of Strongyloidiasis Upon Differentiation of Strongyloides fuelleborni fuelleborni From Strongyloides stercoralis J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-27
Lucas J Cunningham, William D Nevin, Jaco J Verweij, Dora Buonfrate, Salvatore Scarso, Virak Khieu, Angus M O’Ferrall, Sarah Rollason, J Russell StothardMolecular epidemiological surveillance for zoonotic strongyloidiasis is confounded by a genus-specific TaqMan probe assay that conflates Strongyloides fuelleborni fuelleborni with Strongyloides stercoralis. To improve surveillance, we developed and validated a novel duplex species-specific TaqMan probe assay, screening a representative collection of available clinical samples. Our assay was highly
-
Estimating ZIKV seroprevalence in a DENV endemic population: the use of blood donors and multiplex serology to monitor arbovirus outbreaks in the Dutch Caribbean J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-27
Louella M R Kasbergen, Reina S Sikkema, Felicity Chandler, Janko H G van Beek, Yaskara Halabi, Norédiz Lourents, Eugene G Maduro, Izzy Gerstenbluth, Ashley Duits, Marion P G KoopmansBackground The geographic range of flaviviruses is expanding, as evidenced by the increase in dengue virus (DENV) cases and the recent emergence of Zika virus (ZIKV) in the Americas. Studying seroprevalence of flaviviruses in (hyper)endemic regions is challenging due to extensive antibody cross-reactivity. Over the past decade, Aruba and Curaçao have experienced DENV and ZIKV outbreaks, of which the
-
Herpes simplex virus (HSV) neurovirulence across the human lifespan J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-26
A Dutton, C K Hayes, D A Leib, L N AkhtarThe ability of herpes simplex virus (HSV) to establish lifelong latency in sensory neurons makes it one of the most pervasive viruses worldwide. Although most HSV infections are asymptomatic or cause limited cutaneous symptoms, some give rise to serious central nervous system (CNS) manifestations. Both primary HSV infection and subsequent reactivation events can cause viral replication and spread within
-
Evaluating the diagnostic utility of 16S ONT Sequencing in patients with Central Nervous System infections and its usefulness in Antimicrobial Stewardship J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-24
Do Van Dong, Le Thi Kieu Linh, Nguyen Thi Tuyet Nga, Nghiem Xuan Hoan, Nguyen Thi Khanh Linh, Tran Thi Thanh Huyen, Hoang Xuan Quang, Tran Thi Lien, Van Dinh Trang, Vu Viet Sang, Peter G Kremsner, Le Huu Song, Dennis Nurjadi, Thirumalaisamy P VelavanBackground Central nervous system (CNS) infections pose a significant public health challenge in resource-limited settings. Traditional culture-based and targeted molecular diagnostic methods have limitations in sensitivity and speed. This study retrospectively analysed the data and CSF samples from our previous study to assess the diagnostic efficacy of untargeted 16S ONT sequencing compared to conventional
-
Mind the clinic-community gap: how concerned should we be about false positive test results in mass tuberculosis screening? J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-23
Lara D Veeken, Alvaro Schwalb, Katherine C Horton, Raspati C Koesoemadinata, Bachti Alisjahbana, Reinout van Crevel, Rein M G J HoubenCommunity-wide screening for bacteriologically confirmed pulmonary tuberculosis may reduce tuberculosis burden, although concerns of overtreatment remain because of false positive diagnoses due to subpar specificity of current bacteriological tests for screening. Our review and data analysis shows that clinic-based test specificity estimates of Xpert against culture underestimate performance in communities
-
Functional humoral response during intranasal convalescent plasma prophylaxis for SARS-CoV-2 J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-23
Caro Verbrugghe, Rana Abdelnabi, Tania Maes, Birgit Weynand, Philippe Vandekerckhove, Johan Neyts, Hendrik B Feys, Elise WoutersBackground The coronavirus disease 2019 (COVID-19) pandemic has had a profound global impact. Therapeutic strategies to bridge the crucial ‘lockdown’ timespan between the emergence of a new virus and vaccine rollout are needed. Methods We recently demonstrated that intranasal (i.n.) administration of COVID-19 convalescent plasma (CCP) in sentinel hamsters can limit severe acute respiratory syndrome
-
Plasma lipid metabolites differentiate metabolic from viral chronic liver disease J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-23
Kara Wegermann, Joseph E Lucas, Laura Dubois, Rebecca Mangus, Zhong Li, Cynthia A Moylan, Keyur Patel, Susanna NaggieBackground and Aim Lipid metabolism is altered in human immunodeficiency virus (HIV) infection and chronic liver diseases, but common and unique pathways have not been elucidated, limiting prevention and treatment strategies. The aim of this study was to discover lipid metabolite signatures for persons with HIV (PWH), PWH with HCV coinfection (PWH-HCV), and individuals with metabolic dysfunction-associated
-
Escherichia coli Type III Secretion System 2 (ETT2) is Associated with Patient Mortality in Bloodstream Infections J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-23
Joshua T Thaden, Phillip Cox, Paa Kwesi Ankrah, Sanjay Khandelwal, Jeffrey S Bourgeois, Orianna Poteete, Felicia Ruffin, Gowthami Arepally, Granger Sutton, Lauren Brinkac, Thomas H Clarke, Dennis C Ko, Derrick E Fouts, Vance G FowlerBackground Escherichia coli has an extensive accessory genome, though its role in impacting patient mortality is unknown. Methods We performed whole genome sequencing with E. coli bloodstream infection isolates from inpatients at Duke University. Pan-genome analysis was used to identify flexible genomic islands associated with in-hospital attributable mortality (death due to infection). The functions
-
The Cost of Silence: A Call to Protect the Future of HIV Research and Care. J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-22
Loreen Willenberg,William Freshwater,Dawn Averitt,Linda H Scruggs,Marc C E Wagner,Waheedah Shabazz-El,Wanda L London,Paul A Edmonds,Christopher Tunstall,Benedict Sandile Khumalo,Sharon Worth-Hatlee,Orbit Clanton,Derrick Mapp,David Palm,Michael Jentes,Susan Dickerson,Andy Kaytes,Jeff Taylor -
Seroprevalence of Dengue, Zika, and Chikungunya Viruses in Humans and Co-located Macaques in Thailand and Cambodia J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-22
Nanthanida Mongkol, Sophana Chea, Somnang Man, Piseth Ly, Cheata Hou, Sokna Ly, Ratanak Sath, Chanthap Lon, Hok Kry, Chea Huch, Rithea Leang, Rekol Huy, Sophia B Lin, Fanny Sae Wang, Daraka Tongthainan, Wirasak Fungfuang, Sudarat Lijitipoon, Sarocha Suthisawat, Nathamon Kosoltanapiwat, Natanon Panpeth, Stephen S Whitehead, Fabiano Oliveira, Rebecca C Christofferson, Jessica E Manning, Kobporn BoonnakBackground Arboviruses—short for "arthropod-borne viruses"—are transmitted to humans and animals by infected arthropods. Aedes mosquito-borne arboviral diseases such as dengue (DENV), Zika (ZIKV), and chikungunya (CHIKV) impose major public health burdens in Southeast Asia. The potential role of sylvatic reservoirs, such as macaques, in maintaining arboviral transmission remains unclear. Methods We
-
Association of HLA Class I Repertoire Score with Severity of Human Cytomegalovirus Infection in Transplant Patients J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-21
Stephanie Almeida, Marcela Helena Gonçalves-Pereira, Amanda Cristina Martins Bicalho, Taynan Vidigal, Caroline Leonel Campos, Camila Queiroz-Glauss, Cassiene Reis, Ana Carolina Azevedo, Marilia Vilela, Luca Becari, Rafael Formenton Cita, Christian Rosado Rodrigues, Filipe Zanovello, Rafael Lage, Luis Cristóvão Porto, Cristiano Xavier Lima, Helton da Costa SantiagoHuman Cytomegalovirus (HCMV) is a common herpesvirus that typically causes asymptomatic infection but can lead to severe complications in transplant patients due to reactivation. The Human Leukocyte Antigen (HLA) plays a crucial role in antigen presentation and T cell activation, essential for an effective immune response. Understanding HLA-pathogen interactions can help predict susceptibility or resistance
-
Response to letter by Prof Sarman Singh "An ideal Point-of-Care Test for Screening TB Infection". J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-21
E Folkesson,G Fröberg,C Sundling,T Schön,E Södersten,J Bruchfeld -
Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-20
Holly E Baum, Marianna Santopaolo, Ore Francis, Emily J Milodowski, Katrina Entwistle, Elizabeth Oliver, Benjamin Hitchings, Divya Diamond, Amy C Thomas, Ruth E Mitchell, Milla Kibble, Kapil Gupta, Natalie Di Bartolo, Paul Klenerman, Anthony Brown, Begonia Morales-Aza, Jennifer Oliver, Imre Berger, Ash M Toye, Adam Finn, Anu Goenka, Andrew D Davidson, Susan Ring, Lynn Molloy, Melanie Lewcock, KateBackground Immunological memory to vaccination and viral infection involves the coordinated action of B and T cells; thus, integrated analysis of these 2 components is critical for understanding their respective contributions to protection against breakthrough infections (BIs) after vaccination. Methods We investigated cellular and humoral immune responses to severe acute respiratory syndrome coronavirus
-
An ideal Point-of-Care Test for Screening TB Infection. J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-19
Sarman Singh -
-
End of the Pandemic or End of Progress? J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-16
Matifadza Hlatshwayo Davis,Kathleen R Page -
Development of protective immunity against diarrheal disease in early years of life. J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-15
Kurt Hanevik -
A Pivotal Trial in the Decline of TB Sanatoria. J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-15
Petros C Karakousis,Graham Mooney -
Multiple approaches to genetic sequencing to identify hepatitis C virus reinfection among people who inject drugs J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-15
Kyra H Grantz, Raghavendran Anantharam, Abraham J Kandathil, Jeffrey Quinn, Jacqueline Astemborski, Gregory D Kirk, Oluwaseun Falade-Nwulia, Javier Cepeda, David L Thomas, Shruti H Mehta, Amy WesolowskiThe burden of hepatitis C virus (HCV) among persons who inject drugs is determined by dynamics of infection, spontaneous clearance, treatment clearance, treatment failure, and reinfection. Although analysis of HCV sequences is often used to infer the net contribution of these factors, those inferences are complicated by the quasispecies distribution and continued evolution of infection within each
-
Probiotic Lactobacillus species modulate immune responses during vaginal epithelial cell colonization J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-14
Marisa Valentine, Diletta Rosati, Axel Dietschmann, Tim B Schille, Mihai G Netea, Bernhard Hube, Mark S GresnigtBackground Vulvovaginal candidiasis (VVC), mainly caused by Candida albicans, affects approximately 75% of women at least once during their lifetime. VVC is characterized by fungal colonization, which leads to inappropriate local hyperinflammation and symptoms. Although the trigger of C. albicans pathogenicity is often unknown, antibiotic use and vaginal dysbiosis are associated with increased susceptibility
-
Human Papillomavirus Persistence, Recurrence, and Incidence in Early Childhood. J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-14
Eméra Alice Bénard,Ana Maria Carceller,Marie-Hélène Mayrand,Jacques Lacroix,Joseph Niyibizi,Louise Laporte,François Audibert,François Coutlée,Helen Trottier,BACKGROUND Little is known on the vertical transmission of human papillomavirus (HPV) and on the dynamics of HPV among children. Our objective was to determine the risk of HPV recurrence, persistence, and incidence over 2 years of age among children born to HPV-positive mothers. METHODS We conducted the HERITAGE study among pregnant women recruited between 2010 and 2016 in Canada. HPV DNA testing was
-
Placental Malaria Induces Oxidative Stress in Human Syncytiotrophoblast J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-14
Demba Sarr, Alicer K Andrew, Ashish K Shukla, Stephen Mwalimu, Julie M MooreBackground Placental malaria is characterized by the accumulation of Plasmodium falciparum-infected erythrocytes and maternal inflammation in the intervillous spaces of the placenta. These features are associated with placental damage and fetal compromise. However, understanding of the mechanisms that lead to poor pregnancy outcome and interventions targeting excessive host responses to placental malaria
-
Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015–2024) J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-14
Jack McHugh, Supavit Chesdachai, Murray Dunsirn, Nancy Wengenack, Paschalis VergidisAntifungal susceptibility testing among 1,740 Candida parapsilosis blood isolates submitted to a U.S. reference laboratory (2015–2024) revealed a significant increase in fluconazole resistance from 8.2% to 20.3% (odds ratio [OR] per year: 1.13; 95% confidence interval [CI]: 1.06–1.20; p<0.001), with notable acceleration since 2021. Voriconazole resistance remained stable over this period. Micafungin
-
Reevaluating the clinical relevance of bacterial vaginosis-associated immune responses in HIV infection. J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-14
Fangli Yu,Pan Ma,Jie Duan -
A case-cluster of aseptic meningitis associated with a newly identified recombinant echovirus6/CoxsackievirusB1 enterovirus J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-13
Kartikeya Cherabuddi, Massimiliano S Tagliamonte, John A Lednicky, David A Ostrov, Tracey L Moquin, Vishal Kaushik Thoomkuntla, Brian Bourgeois, Vidya Sagar Kollu, Nicole M Iovine, Paul D Myers, Kuttichantran Subramaniam, Marco Salemi, J Glenn MorrisA daycare teacher presented with complaints of headache, neck stiffness, and fever. Because of initial concerns about meningococcal meningitis, families of daycare attendees were notified and 10 children from the daycare presented for evaluation. CSF from the teacher and nasal swabs from four febrile children were RT-PCR positive for enterovirus. A novel recombinant enterovirus was cultured from the
-
Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Using Linked Public Health Information Systems, California, 2023–2024 Season J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-13
Sophie Zhu, Joshua Quint, Tomás León, Monica Sun, Nancy J Li, Cynthia Yen, Mark W Tenforde, Brendan Flannery, Seema Jain, Robert Schechter, Cora Hoover, Erin L MurrayBackground Mandatory public health reporting of influenza laboratory results and vaccine doses administered in the state of California can provide estimates of seasonal influenza vaccine effectiveness (VE). Methods We analyzed linked influenza immunization registry and laboratory reporting data among California residents aged ≥6 months tested for influenza during the 2023–24 influenza season (October
-
Safety, immunogenicity, and protective efficacy in rhesus macaques of a novel recombinant hemagglutinin protein measles virus vaccine J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-13
Jessica H Rubens, Jacqueline K Brockhurst, Shristi Ghimire, Jinjin Wu, Liting Liu, Jason S Villano, Rebecca J Loomis, Alexandrine Derrien-Colemyn, Tracy J Ruckwardt, Barney S Graham, Michael W Watson, Guillaume B E Stewart-Jones, Diane E GriffinBackground Measles-Mumps-Rubella (MMR) is an effective live-virus vaccine against measles but is poorly immunogenic in infants and contraindicated for pregnant and immunocompromised persons. Methods We evaluated immunogenicity and protective efficacy of a novel recombinant dimeric MeV hemagglutinin protein vaccine (rMeV) in rhesus macaques. Macaques (n=4) in four experimental groups were injected at
-
Gastrointestinal Dysmotility, Autonomic Function and Small Intestinal Bacterial Overgrowth among People with Well-Controlled HIV J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-13
Jessica Robinson-Papp, Mitali Mehta, Bridget R Mueller, Niyati Neupane, Zhan Zhao, Gabriela Cedillo, Kaitlyn Coyle, Maya Campbell, Mary Catherine George, Emma K T Benn, Gina Lee, Jack SemlerIntroduction Gastrointestinal dysfunction, including microbiome changes and increased bacterial translocation across a compromised gastrointestinal barrier plays a role in the chronic systemic inflammation experienced by people with HIV (PWH). It is unknown whether autonomic neuropathy (AN) may contribute to these mechanisms by altering gastrointestinal motility. Methods This is a cross-sectional study
-
Streptococcus pyogenes surveillance through surface swab samples to track the emergence of streptococcal toxic shock syndrome in rural Japan J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-13
Dhammika Leshan Wannigama, Mohan Amarasiri, Phatthranit Phattharapornjaroen, Cameron Hurst, Charin Modchang, Yu Suzuki, Kazunori Moriya, Kazuhiko Miyanaga, Longzhu Cui, Angkana T Huang, Yoshikazu Okuma, Daisuke Akaneya, Junko Igarashi, Mayu Suto, Daisuke Ishizawa, Wakana Imamiya, Ayaka Igarashi, Yoshitaka Shimotai, Andrew C Singer, Naveen Kumar Devanga Ragupathi, Takashi Furukawa, Kazunari Sei, YangzhongJapan recently experienced a record surge in streptococcal toxic shock syndrome (STSS). Our environmental surveillance study reveals that Streptococcus pyogenes persists seasonally, peaking in autumn and winter in rural Japan. The dominant emm1 M1UK sublineage and csrS mutations heighten virulence, highlighting the urgent need for targeted surveillance and interventions.
-
Cefepime-Taniborbactam—a Novel Combination Therapy for Multidrug-Resistant Pathogens J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-12
Richard R Watkins, Tracy L Lemonovich, Alejandro J Vila, Robert A BonomoThe ongoing spread of antimicrobial resistance has generated an urgent need for new antibiotics, especially against multidrug-resistant (MDR) gram-negative pathogens. Taniborbactam (previously VNRX-5133) is a novel bicyclic boronate β-lactamase inhibitor with potent, selective, and direct inhibitory activity against Ambler class A, B, C, and D enzymes, including serine and metallo-β-lactamases. Taniborbactam
-
Wastewater Measures of SARS-CoV-2 Accurately Predict Frequency of Symptomatic Infections in the Community J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-08
Charles R Doss, Mark J Osborn, Stacey Stark, Joshua Rhein, Jacalynn Donkersgoed, Donna Budde, Shannon Champeau, Carolyn Meyer, Mason Hayden, Laura Landini, Difan Ouyang, Lappui Chung, Yi Tang, Sara Vetter, Timothy W SchackerBackground Widespread immunity through vaccination or natural infection has altered the predictive ability of wastewater for hospitalization and mortality. Methods Between January 2022 and August 2024, we conducted a longitudinal observational study aimed to examine the correlation between symptomatic COVID-19 in healthcare employees and the SARS-CoV-2 wastewater community levels. Wastewater was analyzed
-
Trust, A Key to Counter Vaccine Hesitancy J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-08
Samer Abdelkader, Akilah A JeffersonVaccines have encountered evolving beliefs due to factors that include historical events, political movements, and unique community values. To combat vaccine hesitancy, dialogue addressing politicization, employing trusted messengers, and acknowledging individuals’ experiences are necessary to build trust.
-
A plasma metabolic signature to diagnose pulmonary tuberculosis and monitor treatment response. J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-08
Jeffrey M Collins,Kidist Bobosha,Naythra Narayanan,Neel R Gandhi,Cheryl L Day,Jyothi Rengarajan,Russell R Kempker,Max S Y Lau,Mary Nellis,Nestani Tukvadze,N Sarita Shah,James C M Brust,Azhar Nizam,Nazir A Ismail,Keith D Kauffman,Shunsuke Sakai,Dean P Jones,Daniel L Barber,Thomas R Ziegler,Joel D Ernst,Henry M Blumberg,Liya Wassie,BACKGROUND High-resolution metabolomics has shown promise for identifying blood-based biomarkers of tuberculosis (TB). We sought to discover a metabolic signature to detect pulmonary TB disease and monitor treatment response. METHODS Plasma from Ethiopian persons with pulmonary TB at diagnosis (n=82) was compared to household contacts with TB symptoms (n=104) and 2, 6, and 12 months after treatment
-
Time to reappraise the antibiotic treatment for methicillin-susceptible Staphylococcus aureus infective endocarditis: data from the experimental model. J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-08
C García-de-la-Mària,O Gasch,M A Cañas,J García-González,F Marco,M Hernández-Meneses,E Quintana,J Ambrosioni,C Falces,J M Tolosana,B Vidal,J M Pericas,A Perissinotti,J Llopis,A Moreno,G Cuervo,J M Miró,BACKGROUND Traditional treatment of methicillin-susceptible Staphylococcus aureus (MSSA) native valve endocarditis is based on cloxacillin/cefazolin monotherapy. Antibiotics with high activity against MSSA such as ceftaroline and daptomycin have been marketed last years, but there are no clinical trials evaluating them as monotherapy or combination therapy in patients with MSSA endocarditis. OBJECTIVES
-
Characterization of serotype-specific Dengue virus T cell inhibition J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-08
Jinhua Xiang, James H McLinden, Qing Chang, Micaela Fosdick, Hillel Haim, Alexander Ploss, Wesley Hottel, Nirjal Bhattarai, Tomokazu Tamura, Jiayu Zhang, Jon C D Houtman, Jack T StapletonBackground Dengue virus (DENV) serotype -2 and -3 infections are associated with more severe disease outcomes than -1 and -4, though a biological explanation for this has not been identified. Methods DENV serotype effects on human T cell activation were assessed by measuring T cell receptor (TCR)-mediated IL-2 release following TCR stimulation. DENV envelope (env) proteins were expressed in Jurkat
-
Tackling HIV Drug Resistance in the Philippines: A Call to Action. J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-07
Jeff Clyde G Corpuz -
Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: a Phase 2a Study in Participants at Low Risk for Acquiring HIV-1 J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-06
Sharon L Hillier, Linda-Gail Bekker, Sharon A Riddler, Craig W Hendrix, Sharlaa Badal-Faesen, Pippa Macdonald, Gonasagrie Nair, Johannes Lombaard, Yoseph Caraco, Avivit Peer, Munjal Patel, Ryan Vargo, Brenda Homony, Katherine Nedrow, Barbara Evans, Prachi Wickremasingha, Yun-Ping Zhou, Valerie Teal, Peggy Hwang, Ciaran McMullan, Keith D Kaufman, Michael N Robertson, Rebeca M PlankBackground Islatravir, a nucleoside reverse transcriptase translocation inhibitor, exhibits high potency against HIV-1, with a long intracellular half-life. The safety, tolerability, and pharmacokinetics of once-monthly oral islatravir were evaluated in adults at low risk of acquiring HIV-1. Methods In this double-blind placebo-controlled trial, participants were randomized 2:2:1 to receive 6 once-monthly
-
Heterogeneous antiretroviral drug exposure in male and female genital tract tissues J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-05
Elias P Rosen, Nicole White, Craig Sykes, Lourdes Adamson, Paul Luciw, Ashlyn Norris, Yuri Fedoriw, Angela D M KashubaBackground Cell-associated HIV has been found in tissues whose architecture can limit antiretroviral drug penetration, including the genital tract. Methods In healthy and SHIV-infected rhesus macaques dosed for 10 days with four-drug combination therapy, we evaluated the spatial distribution of six antiretroviral drugs (ARVs) within the male and female genital tract by mass spectrometry imaging (MSI)
-
The Impact of Diet on Clostridioides difficile Infection: A Review J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-05
Melissa Castro, Heidi J Silver, Keith Hazleton, Catherine Lozupone, Maribeth R NicholsonClostridioides difficile poses a significant public health challenge as it is the leading cause of antibiotic-associated diarrhea and is associated with significant morbidity and mortality. C. difficile’s metabolism and pathogenesis are strongly influenced by nutrient availability from the host and gut commensals. This has caused increasing interest in dietary intake and diet-derived metabolites’ role
-
Authors' reply to Herpes zoster vaccine and cardiovascular disease risk. J. Infect. Dis. (IF 5.0) Pub Date : 2025-04-30
Xinyi Xu,Isabel Ray,Emily Tang,Benjamin F Arnold,Nisha R Acharya